M. Sliwkowski: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Removal of Sialic Acid from a Glycoprotein in CHO Cell Culture Supernatant by Action of an Extracellular CHO Cell Sialidase

Gramer, Michael J., Goochee, Charles F., Chock, Valerie Y., Brousseau, David T., Sliwkowski, Mary B.

Journal:

Year:

1995

File:

PDF, 899 KB

1995

2

Treatment of HER2-positive breast cancer: current status and future perspectives

Arteaga, Carlos L., Sliwkowski, Mark X., Osborne, C. Kent, Perez, Edith A., Puglisi, Fabio, Gianni, Luca

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2011

Language:

english

File:

PDF, 3.26 MB

english, 2011

3

Assessing Genetic Heterogeneity in Production Cell Lines: Detection by Peptide Mapping of a Low Level Tyr to Gln Sequence Variant in a Recombinant Antibody

Harris, Reed J., Murnane, Amy A., Utter, Shannon L., Wagner, Karen L., Cox, Edward T., Polastri, Gian D., Helder, Judith C., Sliwkowski, Mary B.

Journal:

Nature Biotechnology

Year:

1993

File:

PDF, 724 KB

1993

4

Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose

Amrita V. Kamath, Dan Lu, Priyanka Gupta, Denise Jin, Hong Xiang, Anne Wong, Cecilia Leddy, Lisa Crocker, Gabriele Schaefer, Mark X. Sliwkowski, Lisa A. Damico-Beyer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 350 KB

english, 2012

5

Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer

LoRusso, P. M., Weiss, D., Guardino, E., Girish, S., Sliwkowski, M. X.

Journal:

Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 562 KB

english, 2011

6

Identification of Heregulin, a Specific Activator of p185erbB2

Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., Shepard, H. M., Kuang, W.-J., Wood, W. l., Goeddel, D. V., Vandlen,

Journal:

Year:

1992

Language:

english

File:

PDF, 1.35 MB

english, 1992

7

Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer

Krop, I. E., Beeram, M., Modi, S., Jones, S. F., Holden, S. N., Yu, W., Girish, S., Tibbitts, J., Yi, J.-H., Sliwkowski, M. X., Jacobson, F., Lutzker, S. G., Burris, H. A.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 153 KB

english, 2010

8

The influence of heregulins on human Schwann cell proliferation

Levi, AD, Bunge, RP, Lofgren, JA, Meima, L, Hefti, F, Nikolics, K, Sliwkowski, MX

Journal:

Journal of Neuroscience

Year:

1995

Language:

english

File:

PDF, 2.58 MB

english, 1995

9

Ammonium alters N-glycan structures of recombinant TNFR-IgG: Degradative versus biosynthetic mechanisms

Martin Gawlitzek, Thomas Ryll, Jim Lofgren, Mary B. Sliwkowski

Journal:

Biotechnology and Bioengineering

Year:

2000

Language:

english

File:

PDF, 286 KB

english, 2000

10

Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells

G. Mincione, C. Bianco, S. Kannan, G. Colletta, F. Ciardiello, M. Sliwkowski, Y. Yarden, N. Normanno, A. Pramaggiore, N. Kim, D.S. Salomon

Journal:

Journal of Cellular Biochemistry

Year:

1996

Language:

english

File:

PDF, 978 KB

english, 1996

11

Analysis of Heregulin-Induced ErbB2 Phosphorylation with a High-Throughput Kinase Receptor Activation Enzyme-Linked Immunosorbant Assay

Michael D. Sadick, Mark X. Sliwkowski, Andrew Nuijens, Laura Bald, Nancy Chiang, Julie A. Lofgren, Wai Lee T. Wong

Journal:

Analytical Biochemistry

Year:

1996

Language:

english

File:

PDF, 178 KB

english, 1996

12

Simultaneous single-step purification of thiolase and NADP-dependent 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri

Mark X. Sliwkowski, Maris G.N. Hartmanis

Journal:

Analytical Biochemistry

Year:

1984

Language:

english

File:

PDF, 795 KB

english, 1984

13

Labeling of cysteine-containing peptides with 2-nitro-5-thiobenzoic acid

Mark X. Sliwkowski, Rodney L. Levine

Journal:

Analytical Biochemistry

Year:

1985

Language:

english

File:

PDF, 447 KB

english, 1985

14

Protein sorting by high-performance liquid chromatography: I. Biomimetic interaction chromatography of recombinant human deoxyribonuclease I on polyionic stationary phases

J. Cacia, C.P. Quan, M. Vasser, M.B. Sliwkowski, J. Frenz

Journal:

Journal of Chromatography A

Year:

1993

Language:

english

File:

PDF, 546 KB

english, 1993

15

Establishment of Schwann cell lines from normal adult and embryonic rat dorsal root ganglia

Rong-hao Li, Mark X. Sliwkowski, Jeannie Lo, Jennie P. Mather

Journal:

Journal of Neuroscience Methods

Year:

1996

Language:

english

File:

PDF, 8.27 MB

english, 1996

16

Overexpression of HER2/neu in solid tumours: an immunohistochemical survey

H K W Koeppen, B D Wright, A D Burt, P Quirke, A M McNicol, N O Dybdal, M X Sliwkowski, K J Hillan

Journal:

Year:

2001

Language:

english

File:

PDF, 351 KB

english, 2001

17

Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab

Camellia W. Adams, David E. Allison, Kelly Flagella, Leonard Presta, Janet Clarke, Noel Dybdal, Kathleen McKeever, Mark X. Sliwkowski

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 390 KB

english, 2006

18

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Teemu T. Junttila, Guangmin Li, Kathryn Parsons, Gail Lewis Phillips, Mark X. Sliwkowski

Journal:

Breast Cancer Research and Treatment

Year:

2011

Language:

english

File:

PDF, 650 KB

english, 2011

19

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

Nelson L. Jumbe, Yan Xin, Douglas D. Leipold, Lisa Crocker, Debra Dugger, Elaine Mai, Mark X. Sliwkowski, Paul J. Fielder, Jay Tibbitts

Journal:

Journal of Pharmacokinetics and Pharmacodynamics

Year:

2010

Language:

english

File:

PDF, 729 KB

english, 2010

20

The biology of human epidermal growth factor receptor 2

Srividya Sundaresan, Elicia Penuel, Mark X. Sliwkowski

Journal:

Current Oncology Reports

Year:

1999

Language:

english

File:

PDF, 311 KB

english, 1999

21

AN IMPROVED METHOD FOR QUANTITATION OF SULFHYDRYL CONCENTRATION IN TURBID SAMPLES

MARK X. SLIWKOWSKI, J. JEFFREY STRANDHOLM, HAROLD E. SWAISGOOD

Journal:

Journal of Food Science

Year:

1980

Language:

english

File:

PDF, 358 KB

english, 1980

22

Biochemical Characterization of Recombinant Human Nerve Growth Factor

Charles H. Schmelzer, Louis E. Burton, Wai-Pan Chan, Evelyn Martin, Cori Gorman, Eleanor Canova-Davis, Victor T. Ling, Mary B. Sliwkowski, Glynis McCray, Jonathan A. Briggs, Tue H. Nguyen, Gian Polast

Journal:

Journal of Neurochemistry

Year:

1992

Language:

english

File:

PDF, 934 KB

english, 1992

23

10.1038/35052073

Yarden, Yosef, Sliwkowski, Mark X.

Journal:

Nature Reviews Molecular Cell Biology

Year:

2001

Language:

english

File:

PDF, 2.34 MB

english, 2001

24

Ready to partner

Sliwkowski, Mark X.

Journal:

Natural Structural Biology

Year:

2003

Language:

english

File:

PDF, 210 KB

english, 2003

25

Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms

Hollmén, M, Määttä, J A, Bald, L, Sliwkowski, M X, Elenius, K

Journal:

Year:

2009

Language:

english

File:

PDF, 493 KB

english, 2009

26

Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1

Kern, Jeffrey A, Wakita, Robert, Sliwkowski, Mark X

Journal:

Cancer Gene Therapy

Year:

1999

Language:

english

File:

PDF, 543 KB

english, 1999

27

γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175

Schaefer, Gabriele, Fitzpatrick, V Danial, Sliwkowski, Mark X

Journal:

Year:

1997

Language:

english

File:

PDF, 798 KB

english, 1997

28

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

Pegram, Mark, Hsu, Sheree, Lewis, Gail, Pietras, Richard, Beryt, Malgorzata, Sliwkowski, Mark, Coombs, Daniel, Baly, Deborah, Kabbinavar, Fairooz, Slamon, Dennis

Journal:

Year:

1999

Language:

english

File:

PDF, 255 KB

english, 1999

29

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells

Aguilar, Zuleima, Akita, Robert W, Finn, Richard S, Ramos, B Lillian, Pegram, Mark D, Kabbinavar, Fairooz F, Pietras, Richard J, Pisacane, Paul, Sliwkowski, Mark X, Slamon, Dennis J

Journal:

Year:

1999

Language:

english

File:

PDF, 351 KB

english, 1999

30

Heregulins and the ErbB-2/3/4 receptors in gliomas

Manfred Westphal, Leonie Meima, Eva Szonyi, Julie Lofgren, Hildegard Meissner, Wolfgang Hamel, Karoly Nikolics, and Mark X. Sliwkowski

Journal:

Journal of Neuro-Oncology

Year:

1997

Language:

english

File:

PDF, 150 KB

english, 1997

31

Heregulin enhances regenerative proliferation in postnatal rat utricular sensory epithelium after ototoxic damage

J. Lisa Zheng, Gretchen Frantz, Annette K. Lewis, Mark Sliwkowski, Wei-Qiang Gao

Journal:

Brain Cell Biology

Year:

1999

Language:

english

File:

PDF, 720 KB

english, 1999

32

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

Teemu T. Junttila, Robert W. Akita, Kathryn Parsons, Carter Fields, Gail D. Lewis Phillips, Lori S. Friedman, Deepak Sampath, Mark X. Sliwkowski

Journal:

Year:

2009

Language:

english

File:

PDF, 1.48 MB

english, 2009

33

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

Teemu T. Junttila, Robert W. Akita, Kathryn Parsons, Carter Fields, Gail D. Lewis Phillips, Lori S. Friedman, Deepak Sampath, Mark X. Sliwkowski

Journal:

Year:

2011

Language:

english

File:

PDF, 37 KB

english, 2011

34

Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

Howard A. Burris III, Jay Tibbitts, Scott N. Holden, Mark X. Sliwkowski, Gail D. Lewis Phillips

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 851 KB

english, 2011

35

Structural requirements for ErbB2 transactivation

Elicia Penuel, Gabriele Schaefer, Robert W Akita, Mark X Sliwkowski

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.43 MB

english, 2001

36

Preclinical studies with Erlotinib (Tarceva)

Robert W. Akita, Mark X. Sliwkowski

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

37

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

David B Agus, Robert W Akita, William D Fox, Gail D Lewis, Brian Higgins, Paul I Pisacane, Julie A Lofgren, Charles Tindell, Douglas P Evans, Krista Maiese, Howard I Scher, Mark X Sliwkowski

Journal:

Year:

2002

Language:

english

File:

PDF, 450 KB

english, 2002

38

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

Matthew C Franklin, Kendall D Carey, Felix F Vajdos, Daniel J Leahy, Abraham M de Vos, Mark X Sliwkowski

Journal:

Year:

2004

Language:

english

File:

PDF, 818 KB

english, 2004

39

Backbone dynamics of the EGF-like domain of heregulin-α

Wayne J. Fairbrother, Jun Liu, Paul I. Pisacane, Mark X. Sliwkowski, Arthur G. Palmer III

Journal:

Journal of Molecular Biology

Year:

1998

Language:

english

File:

PDF, 707 KB

english, 1998

40

Catalytic effect of sulfhydryl oxidase on the formation of three-dimensional structure in chymotrypsinogen A

Violeta G. Janolino, Mark X. Sliwkowski, Harold E. Swaisgood, H.Robert Horton

Journal:

Archives of Biochemistry and Biophysics

Year:

1978

Language:

english

File:

PDF, 855 KB

english, 1978

41

Nonidentity of sulfhydryl oxidase and γ-glutamyltransferase in bovine milk

Mary B. Sliwkowski, Mark X. Sliwkowski, Harold E. Swaisgood, H.Robert Horton

Journal:

Archives of Biochemistry and Biophysics

Year:

1981

Language:

english

File:

PDF, 651 KB

english, 1981

42

Regulation of the acetylcholine receptor ϵ subunit gene by recombinant ARIA: An in vitro model for transynaptic gene regulation

Gerald C Chu, Lisa M Moscoso, Mark X Sliwkowski, John P Merlie

Journal:

Year:

1995

Language:

english

File:

PDF, 4.68 MB

english, 1995

43

Effects of in Vivo Heregulin β1 Treatment in Wild-Type and ErbB Gene-Targeted Mice Depend on Receptor Levels and Pregnancy

Sue O’Shea, Kent Johnson, Ross Clark, Mark X. Sliwkowski, Sharon L. Erickson

Journal:

The American Journal of Pathology

Year:

2001

Language:

english

File:

PDF, 3.30 MB

english, 2001

44

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4

V.Danial Fitzpatrick, Paul I Pisacane, Richard L Vandlen, Mark X Sliwkowski

Journal:

Year:

1998

Language:

english

File:

PDF, 152 KB

english, 1998

45

Binding specificities and affinities of egf domains for ErbB receptors

Jennifer T Jones, Robert W Akita, Mark X Sliwkowski

Journal:

Year:

1999

Language:

english

File:

PDF, 118 KB

english, 1999

46

An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors

Antony W Burgess, Hyun-Soo Cho, Charles Eigenbrot, Kathryn M Ferguson, Thomas P.J Garrett, Daniel J Leahy, Mark A Lemmon, Mark X Sliwkowski, Colin W Ward, Shigeyuki Yokoyama

Journal:

Year:

2003

Language:

english

File:

PDF, 504 KB

english, 2003

47

Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation

Huang, S., Li, C., Armstrong, E. A., Peet, C. R., Saker, J., Amler, L. C., Sliwkowski, M. X., Harari, P. M.

Journal:

Cancer Research

Year:

2013

Language:

english

File:

PDF, 1.53 MB

english, 2013

48

Beyond Cetuximab for Head and Neck Cancer: Dual Target Antibody Blockade of EGFR and HER3 Enhances Radiosensitivity and Overcomes Acquired Resistance to EGFR Inhibitors

P.M. Harari, S. Huang, C. Li, M.X. Sliwkowski

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2011

Language:

english

File:

PDF, 39 KB

english, 2011

49

208 POSTER Pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of PRO132365, a HER2 antibody-drug conjugte

J. Tibbitts, N. Jumbe, D. Liepold, D. Dugger, L. Crocker, M.X. Sliwkowski, P.J. Fielder, S. Kenkare-Mitra

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

50

Additive anti-neoplastic effect using combination therapy with anti-HER-2 antibodies and celecoxib

Moss Mann, Hongmiao Sheng, Mark Sliwkowsky, Raymond N. DuBois

Journal:

Gastroenterology

Year:

2000

Language:

english

File:

PDF, 192 KB

english, 2000

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски